Prati
Maarten Naesens
Maarten Naesens
Professor, Department of Microbiology, Immunology & Transplantation, KU Leuven
Potvrđena adresa e-pošte na uzleuven.be
Naslov
Citirano
Citirano
Godina
Calcineurin inhibitor nephrotoxicity
M Naesens, DRJ Kuypers, M Sarwal
Clinical Journal of the American Society of Nephrology 4 (2), 481-508, 2009
16102009
The Banff 2017 Kidney Meeting Report: Revised diagnostic criteria for chronic active T cell–mediated rejection, antibody‐mediated rejection, and prospects for integrative …
M Haas, A Loupy, C Lefaucheur, C Roufosse, D Glotz, D Seron, ...
American Journal of Transplantation 18 (2), 293-307, 2018
9922018
The Banff 2019 Kidney Meeting Report (I): Updates on and clarification of criteria for T cell–and antibody‐mediated rejection
A Loupy, M Haas, C Roufosse, M Naesens, B Adam, M Afrouzian, ...
American Journal of Transplantation 20 (9), 2318-2331, 2020
4932020
CYP3A5 and CYP3A4 but not MDR1 Single‐nucleotide Polymorphisms Determine Long‐term Tacrolimus Disposition and Drug‐related Nephrotoxicity in Renal …
DRJ Kuypers, H de Jonge, M Naesens, E Lerut, K Verbeke, ...
Clinical pharmacology & therapeutics 82 (6), 711-725, 2007
2622007
Analyses of the short-and long-term graft survival after kidney transplantation in Europe between 1986 and 2015
M Coemans, C Süsal, B Döhler, D Anglicheau, M Giral, O Bestard, ...
Kidney international 94 (5), 964-973, 2018
2512018
Multidrug resistance protein 2 genetic polymorphisms influence mycophenolic acid exposure in renal allograft recipients
M Naesens, DRJ Kuypers, K Verbeke, Y Vanrenterghem
Transplantation 82 (8), 1074-1084, 2006
2502006
The impact of uridine diphosphate–glucuronosyltransferase 1A9 (UGT1A9) gene promoter region single‐nucleotide polymorphisms T—275A and C—2152T on …
DRJ Kuypers, M Naesens, S Vermeire, Y Vanrenterghem
Clinical Pharmacology & Therapeutics 78 (4), 351-361, 2005
2342005
Prediction system for risk of allograft loss in patients receiving kidney transplants: international derivation and validation study
A Loupy, O Aubert, BJ Orandi, M Naesens, Y Bouatou, M Raynaud, ...
Bmj 366, 2019
2312019
A common rejection module (CRM) for acute rejection across multiple organs identifies novel therapeutics for organ transplantation
P Khatri, S Roedder, N Kimura, K De Vusser, AA Morgan, Y Gong, ...
Journal of Experimental Medicine 210 (11), 2205-2221, 2013
2302013
Intrarenal resistive index after renal transplantation
M Naesens, L Heylen, E Lerut, K Claes, L De Wever, F Claus, R Oyen, ...
New England Journal of Medicine 369 (19), 1797-1806, 2013
2282013
A circulating antibody panel for pretransplant prediction of FSGS recurrence after kidney transplantation
M Delville, TK Sigdel, C Wei, J Li, SC Hsieh, A Fornoni, GW Burke, ...
Science translational medicine 6 (256), 256ra136-256ra136, 2014
2192014
Tertiary ‘hyperphosphatoninism’accentuates hypophosphatemia and suppresses calcitriol levels in renal transplant recipients
P Evenepoel, M Naesens, K Claes, D Kuypers, Y Vanrenterghem
American Journal of Transplantation 7 (5), 1193-1200, 2007
1942007
Bartter’s and Gitelman’s syndromes: from gene to clinic
M Naesens, P Steels, R Verberckmoes, Y Vanrenterghem, D Kuypers
Nephron Physiology 96 (3), p65-p78, 2004
1942004
New insights into the pharmacokinetics and pharmacodynamics of the calcineurin inhibitors and mycophenolic acid: possible consequences for therapeutic drug monitoring in solid …
H de Jonge, M Naesens, DRJ Kuypers
Therapeutic drug monitoring 31 (4), 416-435, 2009
1882009
Recovery of hyperphosphatoninism and renal phosphorus wasting one year after successful renal transplantation
P Evenepoel, BKI Meijers, H de Jonge, M Naesens, B Bammens, K Claes, ...
Clinical journal of the American Society of Nephrology: CJASN 3 (6), 1829, 2008
1832008
The P450 oxidoreductase* 28 SNP is associated with low initial tacrolimus exposure and increased dose requirements in CYP3A5-expressing renal recipients
H De Jonge, C Metalidis, M Naesens, D Lambrechts, DRJ Kuypers
Pharmacogenomics 12 (9), 1281-1291, 2011
1782011
Donor age and renal P-glycoprotein expression associate with chronic histological damage in renal allografts
M Naesens, E Lerut, H de Jonge, B Van Damme, Y Vanrenterghem, ...
Journal of the American Society of Nephrology: JASN 20 (11), 2468, 2009
1702009
Expression of complement components differs between kidney allografts from living and deceased donors
M Naesens, L Li, L Ying, P Sansanwal, TK Sigdel, SC Hsieh, N Kambham, ...
Journal of the American Society of Nephrology: JASN 20 (8), 1839, 2009
1662009
The histology of kidney transplant failure: a long-term follow-up study
M Naesens, DRJ Kuypers, K De Vusser, P Evenepoel, K Claes, ...
Transplantation 98 (4), 427-435, 2014
1622014
Complete steroid avoidance is effective and safe in children with renal transplants: a multicenter randomized trial with three-year follow-up
MM Sarwal, RB Ettenger, V Dharnidharka, M Benfield, R Mathias, ...
American journal of transplantation 12 (10), 2719-2729, 2012
1532012
Sustav trenutno ne može provesti ovu radnju. Pokušajte ponovo kasnije.
Članci 1–20